ICON plc | Clinical Research Organisation (CRO) for Drug Development

wearables smart watch connected for digital health technologies

Closing the evidence gap

The value of digital health technologies in supporting drug reimbursement decisions

Glycomics: the future "sweet spot" in precision medicine diagnostics

The rise of glycan biomarkers in therapeutic development.

Parallel consultation from regulators and HTA bodies in Europe

Opportunities and challenges for drug developers.

Antimicrobial resistance

How clinical research can combat an ensuing global crisis.

Webinars

Upcoming webinar: Reflections on paediatric assent

8 November, 2021. Register now.

Upcoming webinar: ICON’s world children’s day

15 November, 2021. Register now.

On-demand webinars

Visit our webinar channel to access other recent webinars.

Featured Services

Market Access

Expertise in mission-critical pricing, market access, and reimbursement.

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

19 October 2021

The impact of the COVID-19 pandemic on mental health

Learn how the ongoing state of the COVID-19 pandemic has affected the global mental health crisis.

01 October 2021

ICON Joins UNICEF Corporate Vaccine Alliance

ICON is one of seven leading Irish companies that just endorsed an open letter urging fellow corporate leaders to join the UNICEF Corporate Vaccine Alliance.

20 September 2021

Rare disease patients and advocates drive change in public policy

Learn how patient advocacy organisations and rare disease communities are driving change in US public policy to make safe and effective treatment options available to all patients.

19 August 2021

The promise of glycomics in medicine

Glycomics has been a largely overlooked area of study. Nevertheless, it has the potential to have a significant impact on precision medicine and healthcare as a whole.

18 August 2021

Battling HIV on many fronts

Discover how in-home services and a global development strategy can help us get closer to more effective treatments.

17 August 2021

Anatomic pathology in the digital age

The development of new, innovative digital technologies has provided the tools to rethink the way we design and conduct clinical trials. One area that has been particularly impacted by this digital age is anatomical pathology.

06 August 2021

Assessing the need for primary supporting clinical evidence or post-market clinical follow-up under MDR

Discover why identifying the study objective during the planning process for PMCF studies is a critical step in the transition to MDR.

28 June 2021

Legacy devices under MDR/IVDR: a path forward

Regulations from 2017 set stricter requirements on manufacturers product development, data reporting, and quality assurance in place.

23 June 2021

Health Technology Assessment: informal deal between council and European Parliament

In June 2021, representatives of the European Parliament and the Council of European Union reached an agreement to boost cooperation amongst EU member States on HTA.

Services

Sectors

Therapeutics

Innovation

Insights

News & Events

About ICON

Regulatory considerations for biotech

Medical communications in early phase product development

The affordability hurdle for gene therapies

Practical considerations for decentralised & hybrid clinical trials